Condition
Allergic Disorder
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03922087Completed
No-worry Baby Project
NCT04189978UnknownPrimary
Impact of Microbial Exposure of the Habitat at the Time of Birth on the Development of Allergic Diseases.
NCT05442658CompletedPrimary
Importance and Association of Gut Microbiota and Biochemical Metabolites on Children Allergic Disorder
NCT03721263Phase 1CompletedPrimary
Study of ASLAN004 in Healthy Subjects
NCT03344783CompletedPrimary
The Effects of Early Life PUFA and R-TFA on AD: A Systematic Review and Meta-analysis
Showing all 5 trials